Skip to main content
Home
Latest news
Browse topics
Lupus Rheumatoid arthritis Spondyloarthropathies COVID-19 Browse all topics
In focus
Bimekizumab: Dual IL-17A/IL-17F inhibition in SpA Anifrolumab for the treatment of SLE JAK inhibitor safety: Weighing up the data and understanding the risks Rituximab and rheumatology practice in the COVID-19 era Safety snapshot: Upadacitinib in patients with PsA Repurposing rheumatology drugs for COVID-19 Telemedicine in rheumatology: COVID-19 and beyond Managing PsA in resource-limited settings
Conferences
ACR Convergence 2022 EULAR 2022 Congress
About us
Medicine Matters Rheumatology
EXTENDED SEARCH

18-10-2018 | Image

Figure 2

Figure 2: Close-up view X400, polarized light with first order red compensator, showing small strongly birefringent crystals with positive elongation typical of monosodium urate crystals, and also negatively birefringent or mildly birefringent crystals with negative elongation typical of calcium pyrophosphate crystals. Observe that there are some crystals parallel to each other that shine bright blue – urate- and dull yellow –pyrophosphate.

print
PRINT
Image Credits